We demonstrate that CysLT1R represents a novel therapeutic target to prevent metastasis, and strongly support the clinical evaluation of LTRAs in combination with anticancer treatments to prevent metastasis in breast cancer patients. The gene discussed is CYSLTR1; the disease is breast carcinoma.